InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

Summary

The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.

Timeline

Start

2025-01-01

Primary completion

2026-01-01

Completion

2026-04-01

Drugs

Indications